Download presentation
Presentation is loading. Please wait.
Published byCandace Hopkins Modified over 6 years ago
1
POEM Group Online Case Discussion Date: April 1, 2014
1 New Case: CD022: Burkett's Lymphoma (Egypt)
2
POEM Group Online Case Discussion
Date:01/04/2014 Case # 1: CD022 O.M.A
3
Case # 1: Referred by Physician: Referring Hospital:
Patient Initials : O.M.A Nationality: Egyptian Gender: male DOB: Age: 14 Diagnosis: Burkett's lymphoma Date of Diagnosis: 02/02/2014 First Consultation / Follow Up
4
Disease History 14 years old, boy, with left knee mass for which he underwent 3 surgeries in the past 4 years Only In the last operation, the pathology was reviewed ( National Cancer institute ) suggesting malignancy. So he was referred to NCI for further investigation
5
Initial Imaging Work up outside NCI :
05/09/2013: MRI lt. knee : acute osteomyelitis with cystic swelling of abscesses 29/12/2013 : CT angiography of the abdominal Aorta and both lower limb arteries was normal 12/02/2014 : Pathology read as high grade lymphoma 20/02/2014 : IHC was positive for CD 99 and CD45
6
Work up at NCI : 25/02/2014 : BM biopsy and CSF were negative 23/02/2014 : Pathology : tumor cells diffusely +ve for LCA and focally +ve for CD99 , viable tumor cell +ve for CD20 & -ve for CD3 &CD10 , Ki-67 LI is about 100% 24/02/2014 : CT of head , chest ,abdomen and pelvis was normal 03/03/2014 : Bone scan showed lesion at the distal 1/3 of left femur with no evidence of skip lesion or distant bone metastasis
7
Treatment Protocol Patient started on the LMB protocol in 19/03/2014 and for re- evaluation at D8 post induction Due for F/U imaging at D8 post induction.
8
Questions What are the DD for B.lymphoma of bone primary site
Although no sign of metastasis , the pt. considered as group B , concerning the micro-mets. When we can grad a pt. as group What we should consider in the evaluation beside the response for the induction
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.